Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
35
NCT00555828
Safety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial Infarction
Phase: Phase 1/2
Role: Lead Sponsor
Start: Mar 31, 2008
Completion: Dec 31, 2013
NCT00927784
Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD
Phase: Phase 2
Role: Collaborator
Start: Aug 31, 2009
Completion: Feb 28, 2011